← Back to blog
ValueJuly 20, 2026

Buy the Dip Monday: When Analyst Targets Imply 776% Upside and the Yield Is 17%

Top 5 Pixie Picks

Only Pro and Free Trial readers get meta-analysis of the top 5 ranked Value stocks.

Sign in

6. VanEck Gold Miners ETF (GDX)

P/E: 17.02 | Earnings yield: 5.9% | 52w drawdown: -39.2%

GDX offers diversified exposure to gold miners at a 17.02× P/E while sitting 39% below its 52-week high, a drawdown that aligns with individual gold equities on this screen. The earnings yield spread of 1.3% over the 10-year Treasury provides modest relative value, and the ETF structure eliminates single-name operational risk.

The ETF carries no FCF yield, dividend yield, or debt metrics because it aggregates underlying holdings, and the 39% drawdown persists despite rising gold prices, suggesting the market expects miners to lag bullion. Recent news highlights outflows into inverse gold miner products like DUST, which jumped 28% in a month.

The setup here is a pure commodity-leverage play with no margin of safety from cash flow or dividends. If gold prices stall, the 39% drawdown extends further, and the 17× multiple offers no valuation cushion compared to single-name miners trading at 12× or less on this screen.

7. Baker Hughes Company (BKR)

P/E: 17.95 | Earnings yield: 5.6% | 52w drawdown: -20.2%

Baker Hughes trades at an 17.95× P/E with a 12.8% ROIC and 4.6% FCF yield, supported by a 1.6% dividend yield and 0.6% shareholder yield. Analysts see $71.52 as fair value, implying 27% upside from the current $56.17 price, and the company reports earnings July 26 with consensus at $0.48 EPS and $6.5B revenue.

Maria C. Borras and Lorenzo Simonelli filed Form 4 transactions in late June and early July, and the U.S. rig count rose seven units as oil prices climbed back above $80 per barrel. The 2.3% short interest and 20% drawdown suggest modest bearish positioning, and the debt-to-equity of 0.86 is manageable for an energy services company.

Revenue declined 0.3% year-over-year, and the earnings yield spread of 1.0% over the 10-year Treasury is the narrowest on this screen, offering no meaningful relative value. The 17.95× multiple sits at the high end of the value screen, and the company's exposure to oilfield services means earnings volatility if crude prices reverse.

8. GSK plc (GSK)

P/E: 13.36 | Earnings yield: 7.5% | 52w drawdown: -17.1%

GSK trades at a 13.36× P/E with a 19.9% ROIC, 4.1% revenue growth, and a 4.6% FCF yield, supported by a 3.5% dividend yield and 1.4% shareholder yield. Analysts see $57.94 as fair value, implying 13% upside from the current $51.18 price, and the company completed a $10.6B acquisition of Nuvalent while delivering promising interim data for Jemperli in rectal cancer.

Ron Squarer, Christy J. Oliger, and Grant C. Bogle each filed Form 4 transactions in mid-July, and short interest at 0.3% of float signals minimal bearish conviction. The normalized 10-year P/E of 14.32 aligns closely with the current 13.36× multiple, suggesting the valuation is fair on a long-cycle basis.

Debt-to-equity of 1.17 is elevated for a large-cap pharma, and the 17% drawdown persists despite positive pipeline news, signaling either integration concerns from the Nuvalent acquisition or market skepticism about the oncology strategy. The earnings yield spread of 2.9% over the 10-year Treasury provides modest relative value but no dramatic margin of safety.


What to Watch

July 23: Newmont earnings with consensus at $1.99 EPS and $6.3B revenue; gold prices and cost guidance will determine whether the 59% analyst upside target is realistic.

July 26: Baker Hughes reports with consensus at $0.48 EPS and $6.5B revenue; oilfield services activity and crude price assumptions will frame the 27% upside case.

July 28: KLA earnings with consensus at $1.00 EPS and $3.6B revenue; semiconductor capex guidance clarifies whether the 776% analyst target reflects genuine opportunity or stale estimates after the 90% drawdown.

July 30: First Solar reports with consensus at $2.82 EPS and $1.1B revenue; module pricing and 2027 demand visibility will test whether the 14% upside target holds despite 8.5% short interest and 100% insider selling over six months.


Go Deeper

The value screener hunts for earnings yields above the 10-year Treasury, low normalized P/Es, and strong cash flow at depressed prices.
Check out the full screener →

Pro-only analytics

Named tickers from this article open in the app with Pro or an active trial.

Sign in

Stock Pixie Pro

See the full Buy the Dip screen — every pick, every metric, every day.

The app shows up to 10 rows on Free; the top 5 by Pixie rank keep ticker, name, and recent close private. Posts may name the top 5 for context. Pro and trial show every row on the screener, full identifiers, and the rest of Pro.

Start your free trial

Or start with the free Market Brief Digest

Where the market stands before the open, in plain language, every trading day. No account needed.

About the Stock Pixie Score

The Stock Pixie Score is a 0–10 composite that measures how well a stock matches the criteria for that screen. Scores reflect the strength of quantitative signals across valuation, quality, and trend factors weighted for the specific screener. A higher score means stronger alignment; above 8 indicates the algorithm finds the setup compelling across most of the metrics it tracks. It is a filter, not a forecast.

The Fine Print

Stock Pixie is not a registered investment adviser and does not offer financial advice. It is a stock screening platform that scores and ranks stocks using quantitative signals. You are responsible for your own research and investment decisions. Past performance does not guarantee future results.